EN
HI

Piramal Pharma Share price

PPLPHARMA

202.37

1.23 (-0.60%)
NSE
BSE
Last updated on 24 Oct, 2025 | 15:45 IST
BUYSELL
Today's High

206.50

Today's Low

201.77

52 Week Low

181.73

52 Week High

307.90

The current prices are delayed, login to your account for live prices

Piramal Pharma Share Key Metrics

Volume
31.69 L
Market Cap
26899.99 CR
LTQ@LTP
2@202.37
ATP
204.27
Var Margin
19.42 %
Circuit Range
183.24-223.96
Delivery %
39.88 %
Value
64.73 CR
ASM/GSM
No
Market Lot
1

Piramal Pharma Fundamentals

View More
P/E Ratio

274.13

P/B Ratio

3.37

Div. Yield

0.07

Sector P/E

37.45

Sector P/B

3.53

Sec. Div. Yield

0.55

Piramal Pharma Resistance and Support

Pivot 192.24

Resistance

First Resistance

194.48

Second Resistance

196.93

Third Resistance

199.17

Support

First Support

189.79

Second Support

187.55

Third Support

185.1

Piramal Pharma Futures & Options

PPLPHARMA-EQ

202.37

-1.23 (-0.6%)

Piramal Pharma Option Chain

View Price, OI, Greeks & More...
View All

28OCT25

202.60

-1.64 (0.80%)

25NOV25

203.16

-1.52 (0.74%)

30DEC25

204.15

-1.40 (0.68%)

PPLPHARMA|28OCT25 CE 200.00

3.50

-1.5 (-30%)

PPLPHARMA|28OCT25 PE 202.50

1.95

0.3 (18.18%)

Piramal Pharma Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

34.86%

Mutual Fund

13.11%

Insurance

1.49%

Foreign Institutional Investors

30.27%

Domestic Institutional Investors

0.29%

Retail

19.98%

Others

0%

Total Promoters
MAR '25
34.95%
JUN '25
34.86%
SEP '25
34.86%

Piramal Pharma Corporate Actions

DateAgenda
2025-07-28Quarterly Results
2025-05-14Audited Results & Final Dividend
2025-01-28Quarterly Results
2024-10-23Quarterly Results

Piramal Pharma News

Piramal Pharma stock surges 5.5% on solid Q2 earnings show

Oct 24 2024 09:51:53

Piramal Pharma Q2 Results: Net profit jumps over 4-fold to Rs 23 cr; revenue at Rs 2,242 cr

Oct 24 2024 12:12:03

Piramal Pharma to pay USD 407,400 to US-based VetDC Inc to settle dispute

Dec 06 2024 19:51:50

Stocks to buy today: Vedanta, ITC and Piramal Pharma on investors' radar

Dec 18 2024 07:36:53
Read More

About Piramal Pharma

NSE : 11571  
BSE : 543635  
ISIN : INE0DK501011  

Piramal Pharma Management

NamePosition
Mrs. Nandini Piramal Chairperson
Mr. Peter DeYoung Executive Director
View More

Piramal Pharma FAQs

The Buying Price of Piramal Pharma share is 202.37 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Piramal Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Piramal Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Piramal Pharma shares is 274.13. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Piramal Pharma shares is 3.37. Useful to assess the stock's value relative to its book value.

To assess Piramal Pharma’s valuation compare Sector P/E, P/B which are 37.45 & 3.53 with sector averages, along with growth rates and financial metrics.

The Market Cap of Piramal Pharma is 26899.99 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Piramal Pharma share price is 307.90 & 181.73. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Piramal Pharma belongs to the Healthcare sector.